Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C.
Among patients with uterine cervical cancer, glassy-cell carcinoma is very rare. The disease occurs mainly in younger patients, is rapidly progressive, and has a poor prognosis. We describe a case of glassy-cell carcinoma of the uterine cervix, in which preoperative intra-arterial chemotherapy was surprisingly effective.
Mikami
M
M
Ezawa
S
S
Sakaiya
N
N
Komuro
Y
Y
Tei
C
C
Fukuchi
T
T
Mukai
M
M
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018196:Carcinoma, Adenosquamous / Q000175:diagnosis / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D008279:Magnetic Resonance Imaging; D016685:Mitomycin / Q000008:administration & dosage; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
D015251:Epirubicin; D016685:Mitomycin; D002945:Cisplatin